Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2527183 | Clinical Therapeutics | 2013 | 12 Pages |
Abstract
Although controlled-release simvastatin significantly reduces LDL-C levels with good tolerability in Korean adults with dyslipidemia, the time of administration does not affect its efficacy.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Sang-Hyun MD, PhD, Min-Kyung MD, Hong-Seok MD, PhD, Min-Soo MD, PhD, Kyoo-Rok MD, PhD, Seong-Wook MD, PhD, Young-Kwon MD, PhD, Seong MD, PhD,